Friday, December 18, 2020

Are Countries Performing Sufficient COVID-19 Tests Globally? - Arizton

COVID-19 Testing

 

The global COVID-19 diagnostics market by tests is segmented into the PCR, antibody (serology) tests, antigen Tests. The PCR accounted for the share of 75 % in the global market. Real-time polymerase chain reaction (RT-PCR) tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. The WHO has recommended PCR as one of the reliable tests for COVID-19 diagnostic and is followed across the globe to diagnose patients and stop the spread of the disease further. As the pandemic continues, vendors have come up with advanced antibody and antigen tests. Many countries with limited healthcare infrastructure have used a lot of antigen and antibody testing for screening. However, PCR remains a confirmatory test in the market.

 

COVID-19 Country-wise Testing

 

APAC is the largest market for the COVID-19 diagnostics market and retains it during the forecast year due to its higher population. This is attributed to the increasing target pool of people requiring disease diagnostics and improvement in healthcare infrastructure. North America accounted for 25% and is the second-largest market. The US, with developed healthcare infrastructure, is still struggling to contain the spread of the virus. The country has recorded the second-highest tests after APAC. It accounts for more than 82% of the tests conducted in the region, followed by 12% of the antigen tests and 5% of the antibody tests conducted in the country.

 

Request for Free Sample

 

The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2020–2026. 

The following factors are likely to contribute to the growth of the COVID-19 diagnostics market during the forecast period:

  • Increased Demand for Mass Testing
  • Demand for Molecular Diagnostics due to Covid-19 Pandemic
  • Unavailability of Specific Medicines/ Vaccines

 

The study considers the present scenario of the COVID-19 diagnostics market and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

 

Prominent Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Siemens Healthineers
  • Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Danaher
  • BD

Other Prominent Vendors

  • Abingdon Health
    • Business Overview
    • Product Offerings
  • ACCESS BIO
  • Assure Tech. (Hangzhou)
  • Autobio Diagnostics
  • Advaite
  • Babson Diagnostics
  • Beijing Wantai Biological
  • Biomerica
  • bioMérieux
  • Biopanda Reagents
  • Biocerna
  • Biocan Diagnostics
  • BioMedomics
  • Clinical Reference Laboratory
  • Cellex
  • The Center for Chest Diseases and Prevention (CDC)
  • CTK Biotech
  • DiaSorin
  • Diazyme Laboratories
  • Erba Mannheim
  • Edinburgh Genetics
  • Eurofins Scientific
  • GenScript
  • Healgen Scientific
  • Hangzhou AllTest Biotech
  • Hangzhou Biotest Biotech
  • Jiangsu Well Biotech
  • Kabla Diagnostics
  • Luminex
  • Meridian Bioscience
  • Megna Health
  • Microgen
  • MP Biomedicals
  • Nova Tech Immunodiagnostica
  • NOWDiagnostics
  • Quotient
  • QIAGEN
  • Quidel
  • Sekisui Diagnostics
  • Sinocare
  • SureScreen Diagnostics
  • Salofy Oy
  • Shenzhen New Industries Biomedical Engineering (SNIBE)
  • Sysmex
  • SEASUN BIOMATERIALS
  • Vibrant America
  • Warrior Diagnostics
  • Xiamen Biotime Biotechnology
  • Zuhai Livzon Diagnostic

 

By Product

  • Consumables
  • Analyzers/Instruments

By Test 

  • PCR
  • Antigen
  • Antibody

By Technology  

  • Molecular
  • Immunology

By End-user

  • Laboratories
  • Hospitals
  • Ambulatory Care Settings
  • Research Institutes 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
    • Indonesia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Peru
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey
    • Iran

 

Looking for More Information? Click Here

 

Source: COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026 by Arizton Advisory & Intelligence

 

About Arizton Advisory & Intelligence 

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence

Chicago, Illinois, 60605

Mail: enquiry@arizton.com

Call: +1-312-235-2040/+1 302 469 0707

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/covid-19-diagnostics-market-size-analysis